The aim of this study was to investigate the effects of heparin on the activity of osteoblast-like cells seeded on poly(caprolactone) (PCL) membranes. The membranes were prepared by solvent-casting technique in ~150 µm thickness. Then they were treated with 1,6-hexanediamine solution and functionalized with covalently bound heparin. The morphology, proliferation, and differentiation of MC3T3-E1 preosteoblasts on these membranes were investigated in vitro. The heparin functionalized PCL membranes, compared to non-functionalized membranes, significantly stimulated osteoblast proliferation. The Scanning electron microscope images confirmed the stimulative effect of covalently bound heparin on the osteoblast-like cell proliferation. The alkaline phosphatase and osteocalcin levels for cells proliferated on heparin containing PCL membranes were higher than that of nonfunctionalized membranes.
Day JRS, Landis RC and Taylor KMHeparin is much more than just an anticoagulant. J Cardiothor Vasc Anesth2004; 18(1): 93-100.
2.
Zhu AP, Ming Z. and Jian S.Blood compatibility of chitosan/heparin complex surface modified ePTFE vascular graft. Appl Surf Sci2005; 241(3-4): 485-492.
3.
Marconi W., Benvenuti F. and Piozzi A.Covalent bonding of heparin to a vinyl copolymer for biomedical applications . Biomaterials1997; 18(12): 885-890.
4.
Che AF, Nie FQ, Huang XD, Xu ZK and Yao K.Acrylonitrile-based copolymer membranes containing reactive groups: surface modification by the immobilization of biomacromolecules. Polymer2005; 46(24): 11060-11065.
5.
Lin DJ, Lin DT, Young TH, Huang FM, Chen CC and Cheng LPImmobilization of heparin on PVDF membranes with microporous structures . J Membrane Sci2004; 245: 137-146.
6.
Lee JS, Go DH, Bae JW, Lee SJ and Park KDHeparin conjugated polymeric micelle for long-term delivery of basic fibroblast growth factor. J Control Release2007; 117: 204-209.
7.
Ishihara M., Sato M., Hattori H., Saito Y., Yura H., Ono K., et al. Heparin-carrying polystyrene (HCPS)-bound collagen substratum to immobilize heparin-binding growth factors and to enhance cellular growth . J Biomed Mater Res A2001; 56(4): 536-544.
8.
Tabata Y. and Ikada Y.Vascularization effect of basic fibroblast growth factor released from gelatin hydrogels with different biodegradabilities. Biomaterials1999; 20(22): 2169-2175.
9.
Tanihara M., Suzuki Y., Yamamoto E., Noguchi A. and Mizushima Y.Sustained release of basic fibroblast growth factor and angiogenesis in a novel covalently crosslinked gel of heparin and alginate. J Biomed Mater Res A, 2001; 56(2): 216-221.
Benoit DSW and Anseth KSHeparin functionalized PEG gels that modulate protein adsorption for hMSC adhesion and differentiation. Acta Biomater2005; 1(4): 461-470.
12.
Nie T., Baldwin A., Yamaguchi N. and Kiick KLProduction of heparin-functionalized hydrogels for the development of responsive and controlled growth factor delivery systems. J Control Release2007; 122(3): 287-296.
13.
Wissink MJB , Beernink R., Scharenborg NM, Poot AA, Engbers GHM, Beugeling T., et al. Endothelial cell seeding of (Heparinized) collagen matrices: effects of bFGF pre-loading on proliferation (after low density seeding) and pro-coagulant factors. J Control Release2000; 67(2-3): 141-155.
14.
Benoit DSW , Colins SD and Anseth KSMultifunctional hydrogels that promote osteogenic hMSC differentiation through stimulation and sequestering of BMP2. Adv Funct Mater2007; 17(13): 2085-2093.
15.
Jeon O., Song SJ, Yang HS, Bhang SH, Kang SW, Sung MA, et al. Long-term delivery enhances in-vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery. Biochem Biophys Res Commun2008; 369(2): 774-780.
16.
Takada T., Katagiri T., Ifuku M., Morimura N., Kobayashi M., Hasegawa K., et al. Sulfated polysaccharides enhance the biological activities of bone morphogenetic proteins. J Biol Chem2003 ; 278: 43229-43235.
17.
Zhao B., Katagiri T., Toyoda H., Takada T., Yanai T., Fukuda T., et al. Heparin potentiates the in-vivo ectopic bone formation induced by bone morphogenetic protein-2. J Biol Chem2006; 281: 23246-23253.
18.
Benoit DSW , Durney AR and Anseth KSThe effect of heparin-functionalized PEG hydrogels on three-dimensional human mesenchymal stem cell osteogenic differentiation . Biomaterials2007; 28(1): 66-77.
19.
Thornton SC , Mueller SN and Levine EMHuman endothelial cells: use of heparin in cloning and long-term serial cultivation. Science1983; 222: 623-625.
20.
Gospodarowicz D. and Cheng J.Heparin protects basic and acidic FGF from inactivation. J Cell Physiol1986 ; 128(3): 475-484.
21.
Zhu A., Zhang M., Wu J. and Shen J.Covalent immobilization of chitosan/heparin complex with a photosensitive hetero-bifunctional crosslinking reagent on PLA surface. Biomaterials2002; 23(23): 4657-4665.
22.
Turkoglu SH , Aday S. and Gümüşderelioğlu M.Insulin and heparin coimmobilized 3D polyester fabrics for cultivation of fibroblasts in low-serum media. Int J Biol Macromol2007; 41(3): 338-345.
23.
Gümüşderelioğlu M. and Aday S.Heparin-functionalized chitosan scaffolds for bone tissue engineering. Carbohydr Res2011; 346: 606-613.
24.
Woodruff MA and Hutmacher DWThe return of a forgotten polymer-polycaprolactone in the 21st century. Prog Polym Sci2010 ; 35: 1217-1256.
25.
Beşkardeş I. and Gümüşderelioğlu M.Biomimetic apatite coated PCL scaffolds: effect of surface topography on cellular functions. J Bioact Compat Polym2009; 24: 507-524.
26.
Şaşmazel HT, Manolache S. and Gümüşderelioğlu M.Water/O2 plasma assisted treatment of PCL membranes for biosignal immobilization . J Biomater Sci Polym Ed2009; 20(7-8): 1137-1162.
27.
Zhu Y., Gao C., Liu X. and Shen J.Surface modification of polycaprolactone membrane via aminolysis and biomacromolecule immobilization for promoting cytocompatibility of human endothelial cells . Biomacromolecules2002; 3: 1312-1319.
28.
Santiago LY , Nowak RW, Peter Rubin J. and Marra KGPeptide-surface modification of polycaprolactone with laminin-derived sequences for adipose-derived stem cell applications . Biomaterials2006 ; 27(15): 2962-2969.
29.
Karakeçili A., Satriano C., Gümüşderelioğlu M. and Marletta G.Relationship between the fibroblastic behavior and surface properties of RGDimmobilized PCL membranes. J Mater Sci Mater Med2007; 18: 317-319.
30.
Kang IK, Kwon OH, Lee YM and Sung YKPreparation and surface characterization of functional group grafted and heparin immobilized polyurethanes by plasma glow discharge. Biomaterials1996; 17(8): 841-847.
31.
McCauley LK , Koh AJ, Beecher CA, Cui Y., Decker JD and Franceschi RTEffects of differentiation and transforming growth factor beta 1 on PTH/PTHrP receptor mRNA levels in MC3T3-E1 cells. J Bone Miner Res1995; 10(8): 1243-1255.
32.
Hatefi Y.The mitochondrial electron transport and oxidative phosphorylation system . Annu Rev Biochem1985; 54: 1015-1069.
33.
Kreke MR, Badami AS, Brady JB, Akers RM and Goldstein ASModulation of protein adsorption and cell adhesion by poly(allyamine hydrochloride) heparin films. Biomaterials2005; 26(16): 2975-2981.
34.
Murakami Y. , Kojima T., Nagasawa T., Kobayashi H. and Ishikawa I.Novel isolation of alkaline phosphatase-positive subpopulation from periodontal ligament fibroblasts . J Periodontol2003; 74(6): 780-786.
35.
Lian JB and Stein GSConcepts of osteoblast growth and differentiation:basis for modulation of bone cell development and tissue formation. Crit Rev Oral Biol Med1992; 3(3): 269-305.
36.
Gupta P., Pan C., Nelson M. and Reyes M.Heparan sulfate oligosaccharides modulate the proliferation and differentiation of human multipotent progenitor cells. Blood2002; 100: 525A.
37.
Franceschi RTThe developmental control of osteoblast-specific gene expression: role of specific transcription factors and the extracellular matrix environment. Crit Rev Oral Biol Med1999; 10(1): 40-57.
